Regenxbio Inc (RGNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 57,526 | 34,522 | 96,952 | 345,209 | 338,426 |
| Marketable Securities | 177,161 | 240,736 | 267,690 | 112,230 | 137,314 |
| Receivables | 20,473 | 24,790 | 28,082 | 32,439 | 42,999 |
| Other current assets | 13,774 | 20,403 | 9,352 | 10,196 | 1,953 |
| TOTAL | $278,001 | $334,971 | $415,976 | $518,826 | $531,197 |
| Non-Current Assets | |||||
| PPE Net | 117,589 | 132,103 | 141,685 | 131,547 | 56,467 |
| Investments And Advances | 10,179 | 38,871 | 200,560 | 391,907 | 46,809 |
| Other Non-Current Assets | 60,220 | 68,025 | 75,047 | 71,624 | 73,691 |
| TOTAL | $187,988 | $238,999 | $417,292 | $595,078 | $176,967 |
| Total Assets | $465,989 | $573,970 | $833,268 | $1,113,904 | $708,164 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 22,798 | 22,786 | 27,213 | 11,387 | 10,622 |
| Accrued Expenses | 38,070 | 49,703 | 46,794 | 76,111 | 49,082 |
| Other current liabilities | 34,309 | 50,567 | 48,601 | 37,889 | 18,794 |
| TOTAL | $103,194 | $130,272 | $130,434 | $130,472 | $81,447 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 115 | 148 | 1,829 | 3,333 | 449 |
| Other Non-Current Liabilities | 103,144 | 131,956 | 186,639 | 219,134 | 245,181 |
| TOTAL | $103,144 | $131,956 | $186,639 | $219,134 | $248,964 |
| Total Liabilities | $206,338 | $262,228 | $317,073 | $349,606 | $330,411 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 50,086 | 44,428 | 43,464 | 42,950 | 42,498 |
| Common Shares | 5 | 4 | 4 | 4 | 4 |
| Retained earnings | -932,149 | -705,047 | -441,553 | -161,232 | -289,072 |
| Other shareholders' equity | -741 | -4,429 | -15,401 | -2,569 | -360 |
| TOTAL | $259,651 | $311,742 | $516,195 | $764,298 | $377,753 |
| Total Liabilities And Equity | $465,989 | $573,970 | $833,268 | $1,113,904 | $708,164 |